Cidara Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cidara Therapeutics Inc
TickerCDTX
CIK #0001610618
CUSIP171757107
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address6310 Nancy Ridge Drive Suite 101, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2025
[0001610618] 10-K
[0001610618] 10-Q
[0001610618] 3
[0001610618] 4
[0001610618] 8-K
[0001610618] D
[0001610618] SC 13D
[0001610618] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Paradigm Biocapital Advisors LP Cidara Therapeutics Inc [2025-07-30] 0.0
BlackRock Inc Cidara Therapeutics Inc [2025-07-17] 0.0
Commodore Capital LP Cidara Therapeutics Inc [2025-07-02] 0.0
Adage Capital Management LP Cidara Therapeutics Inc [2025-05-12] 0.0
Point72 Asset Management LP Cidara Therapeutics Inc [2025-04-16] 0.0
Vivo Opportunity Fund Holdings LP Cidara Therapeutics Inc [2024-12-09] 5.5
Venrock Healthcare Capital Partners III LP Cidara Therapeutics Inc [2024-12-04] 0.99
TCG Crossover GP II LLC Cidara Therapeutics Inc [2024-12-03] 81949.2
Canaan XII LP Cidara Therapeutics Inc [2024-07-29] 8194.0
BCLS Fund III Investments LP Cidara Therapeutics Inc [2024-07-29] 81949.99
RA Capital Management LP Cidara Therapeutics Inc [2024-07-25] 0.99
Nantahala Capital Management LLC Cidara Therapeutics Inc [2022-02-14] 7.9
Point72 Asset Management LP Cidara Therapeutics Inc [2021-10-14] 6.3
Lytton Laurence W Cidara Therapeutics Inc [2021-03-05] 5.7
Stonepine Capital Management LLC Cidara Therapeutics Inc [2020-02-21] 5.0
Opaleye Management Inc Cidara Therapeutics Inc [2020-02-21] 11.0
Mundipharma AG Cidara Therapeutics Inc [2019-09-13] 15.2
Omega Fund V LP Cidara Therapeutics Inc [2019-02-13] 5.4
Biotechnology Value Fund L P Cidara Therapeutics Inc [2018-06-04] 6.5
Opaleye Management Inc Cidara Therapeutics Inc [2018-06-04] 11.0
Broadfin Capital LLC Cidara Therapeutics Inc [2017-07-13] 5.28
ProSight Management LP Cidara Therapeutics Inc [2017-06-16] 5.2
Lytton Laurence W Cidara Therapeutics Inc [2016-11-14] 5.3
Aisling Capital II LP Cidara Therapeutics Inc [2016-05-17] 7.4
BB Biotech AG Cidara Therapeutics Inc [2016-04-04] 5.4
Frazier Healthcare VII LP Cidara Therapeutics Inc [2016-03-29] 0.56
5AM Ventures III LP Cidara Therapeutics Inc [2016-02-12] 14.3
FMR LLC Cidara Therapeutics Inc [2015-09-10] 0.0
InterWest Partners X LP Cidara Therapeutics Inc [2015-04-23] 11.0
RA Capital Management LLC Cidara Therapeutics Inc [2015-04-21] 7.2
Form 3/4/5 Filer 2011 - 2025
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
Cidara Therapeutics, Inc.
Shah Rajeev M.
Mineo Chrysa
Merson James
Canale-Theakston Carin
Spencer Ryan
Schroeder Theodore R
Resnick Joshua
Burgess Daniel D
Bassler Bonnie L
Davarpanah Nicole Negar
Ward Shane
Stein Jeffrey
Tari Leslie
Karbe Frank
Sandison Taylor
Shah Preetam
Tadvalkar Laura
Franson Timothy R
Gollaher David L
Daruwala Paul
Johnson Brady
Oien Jessica
Abdollahian Neil
Levine James E.
Mundipharma AG
Rocklage Scott M
Onaitis Matthew
Biotech Target N V
BB Biotech AG
Wilson Marc
Perez Robert J
Forrest Kevin
Bartizal Ken
Thye Dirk
Kjellson Nina S
5AM Ventures III LP
5AM Co-Investors III, L.P.
Schwab Andrew J.
Diekman John D
Elms Steve
Heron Patrick J
Judice Kevin
Schiff Andrew N
Aisling Capital II LP
Aisling Capital Partners LP
Aisling Capital Partners LLC
Seachaid Pharmaceuticals, Inc.
Purcell Dennis J
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2025-06-30] SOLE 3,365,523 3,365,523
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 2,500,680 2,500,680
Point72 Asset Management LP [2025-06-30] DFND 0 1,527,930
Vivo Capital LLC [2025-06-30] SOLE 1,311,425 1,311,425
Ikarian Capital LLC [2025-06-30] SOLE 1,287,088 1,287,088
Commodore Capital LP [2025-06-30] SOLE 1,175,000 1,175,000
BlackRock, Inc. [2025-06-30] SOLE 1,081,502 1,107,668
Adage Capital Partners GP LLC [2025-06-30] SOLE 1,100,000 1,100,000
TCG Crossover Management LLC [2025-06-30] SOLE 1,005,901 1,005,901
Vanguard Group Inc [2025-06-30] SOLE 0 953,973
Morgan Stanley [2025-06-30] DFND 877,615 883,415
BVF Inc/IL [2025-06-30] DFND 0 786,392
Darwin Global Management, Ltd. [2025-06-30] SOLE 768,424 768,424
VR Adviser LLC [2025-06-30] SOLE 639,088 639,088
Janus Henderson Group PLC [2025-06-30] DFND 0 625,000
Caption Management LLC [2025-06-30] SOLE 608,900 608,900
Vestal Point Capital LP [2025-06-30] SOLE 500,000 500,000
Susquehanna International Group LLP [2025-06-30] OTR 54,840 474,840
Soleus Capital Management LP [2025-06-30] SOLE 462,811 462,811
Boothbay Fund Management LLC [2025-06-30] OTR 0 453,926
Jefferies Financial Group Inc. [2025-06-30] DFND 450,000 450,000
Geode Capital Management LLC [2025-06-30] DFND 372,010 372,010
Citadel Advisors LLC [2025-06-30] DFND 364,151 364,151
Sofinnova Investments Inc [2025-06-30] SOLE 351,031 351,031
Stempoint Capital LP [2025-06-30] SOLE 233,070 266,774
Aberdeen Group plc [2025-06-30] DFND 259,916 259,916
LMR Partners LLP [2025-06-30] SOLE 258,200 258,200
Deep Track Capital LP [2025-06-30] SOLE 250,000 250,000
Marshall Wace LLP [2025-06-30] OTR 0 242,779
State Street Corp [2025-06-30] DFND 214,737 236,937
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com